公司资料
Henry Schein 股价、新闻与催化剂
- 股票代码:
- HSIC
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
89.52 USD (-0.28%)
收盘价
最后更新: 2026年8月17日
8.66B USD
市值
股价为何变动
As of Aug 17, 2026, HSIC closed down 0.28% at $89.52. No new same-company headline was identified in the current news window.
公司概览
业务概览
Henry Schein is a global distributor of healthcare and dental products, with businesses spanning clinical supplies, equipment, and software. Its role is centered on healthcare distribution and practice support rather than biotech or medtech innovation.
所在地与行业分类
Headquartered in the United States and listed on NASDAQ, Henry Schein has a global distribution footprint. It sits in healthcare distribution and dental supply rather than biotechnology.
商业模式特征
The company generates revenue from product distribution, equipment sales, and software services for providers. Investors watch end-market demand, margin stability, and the health of dental and medical office spending.
生物医药行业定位
Henry Schein is outside biotech, but it is part of the healthcare infrastructure that keeps clinical and dental practices operating. It moves on distribution volumes and practice demand, not drug catalysts.
未来催化剂
- Henry Schein’s catalysts are dental-market recovery, software adoption, and inventory / margin discipline. The key question is whether the update shows enough repeatable demand to look like a durable revenue driver rather than a one-quarter bump. If adoption broadens, sentiment can improve faster than the reported numbers alone would suggest.
近期新闻
- 01
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。